ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Shire Pharmaceuticals Limited

Shire Pharmaceuticals Limited is an active company incorporated on 26 June 1986 with the registered office located in London, Greater London. Shire Pharmaceuticals Limited was registered 39 years ago.
Status
Active
Active since incorporation
Company No
02031674
Private limited company
Age
39 years
Incorporated 26 June 1986
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 28 June 2025 (4 months ago)
Next confirmation dated 28 June 2026
Due by 12 July 2026 (8 months remaining)
Last change occurred 2 years 4 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Full
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
1 Kingdom Street
London
W2 6BD
United Kingdom
Address changed on 2 Dec 2024 (11 months ago)
Previous address was
Telephone
01256894000
Email
Available in Endole App
Website
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Feb 1985
Director • Turkish • Lives in England • Born in Mar 1979
Director • Finance Director • American • Lives in England • Born in Mar 1981
Takeda UK Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Shire Pharmaceutical Contracts Limited
Peter Michael Grubin, Seyda Atadan Memis, and 1 more are mutual people.
Active
Takeda Development Centre Europe Ltd
Peter Michael Grubin, Seyda Atadan Memis, and 1 more are mutual people.
Active
Takeda UK Limited
Peter Michael Grubin and Seyda Atadan Memis are mutual people.
Active
Takeda Cambridge Limited
Peter Michael Grubin and Marc Stuart Page are mutual people.
Active
Gammadelta Therapeutics Ltd
Seyda Atadan Memis is a mutual person.
Active
Adaptate Biotherapeutics Ltd
Seyda Atadan Memis is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2013–2023)
Period Ended
31 Mar 2023
For period 31 Mar31 Mar 2023
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£5.03M
Decreased by £5.12M (-50%)
Total Liabilities
£0
Decreased by £2.3M (-100%)
Net Assets
£5.03M
Decreased by £2.82M (-36%)
Debt Ratio (%)
0%
Decreased by 22.66% (-100%)
Latest Activity
Peter Michael Grubin Resigned
2 Months Ago on 2 Sep 2025
Mr Marc Stuart Page Appointed
2 Months Ago on 19 Aug 2025
Confirmation Submitted
4 Months Ago on 11 Jul 2025
Mr Peter Michael Grubin Details Changed
5 Months Ago on 29 May 2025
Full Accounts Submitted
10 Months Ago on 18 Dec 2024
Registers Moved To Inspection Address
11 Months Ago on 2 Dec 2024
Inspection Address Changed
11 Months Ago on 29 Nov 2024
Confirmation Submitted
1 Year 4 Months Ago on 10 Jul 2024
Full Accounts Submitted
1 Year 7 Months Ago on 7 Apr 2024
Ms Seyda Atadan Memis Details Changed
2 Years 2 Months Ago on 1 Sep 2023
Get Credit Report
Discover Shire Pharmaceuticals Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Peter Michael Grubin as a director on 2 September 2025
Submitted on 10 Sep 2025
Appointment of Mr Marc Stuart Page as a director on 19 August 2025
Submitted on 28 Aug 2025
Confirmation statement made on 28 June 2025 with no updates
Submitted on 11 Jul 2025
Director's details changed for Mr Peter Michael Grubin on 29 May 2025
Submitted on 10 Jul 2025
Full accounts made up to 31 March 2024
Submitted on 18 Dec 2024
Register(s) moved to registered inspection location 2 New Street Square London EC4A 3BZ
Submitted on 2 Dec 2024
Register inspection address has been changed from 1 Kingdom Street London W2 6BD United Kingdom to 2 New Street Square London EC4A 3BZ
Submitted on 29 Nov 2024
Confirmation statement made on 28 June 2024 with no updates
Submitted on 10 Jul 2024
Full accounts made up to 31 March 2023
Submitted on 7 Apr 2024
Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
Submitted on 19 Feb 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year